Subscribe

What are you looking for?

Main Menu

明報新聞網

三葉草生物終止國光協議 停在內地分銷四價季節性流感疫苗

Future Wealths
Future Wealths
16 6 月, 2025
One Min Read
11 Views
0 Comments
三葉草生物－Ｂ(2197)公布，鑒於市場狀況出現重大變化，集團行使獨家協議項下之單方終止權，向國光生技發出通知以終止獨家協議，停止包括但不限於在中國大陸分銷四價季節性流感疫苗，6月30日生效。

原文: https://finance.mingpao.com/fin/instantf/20250616/1750035676682/%e4%b8%89%e8%91%89%e8%8d%89%e7%94%9f%e7%89%a9%e7%b5%82%e6%ad%a2%e5%9c%8b%e5%85%89%e5%8d%94%e8%ad%b0-%e5%81%9c%e5%9c%a8%e5%85%a7%e5%9c%b0%e5%88%86%e9%8a%b7%e5%9b%9b%e5%83%b9%e5%ad%a3%e7%af%80%e6%80%a7%e6%b5%81%e6%84%9f%e7%96%ab%e8%8b%97

Last Update: 16 6 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept